$IVAC
INTEVAC INC Stock $ivac

$ivac Overview Financials Valuation SEC Filings Company Website

2013 Q3 Form 10-Q Financial Statement

#000119312513310182 Filed on July 30, 2013

Income Statement

Concept	2013 Q3	2013 Q2	2012 Q2
Revenue	$19.12M	$16.98M	$31.79M
YoY Change	13.55%	-46.58%	82.47%
Cost Of Revenue	$12.22M	$13.15M	$17.54M
YoY Change	10.07%	-24.99%	58.85%
Gross Profit	$6.895M	$3.829M	$14.25M
YoY Change	20.29%	-73.14%	123.42%
Gross Profit Margin	36.07%	22.55%	44.84%
Selling, General & Admin	$5.627M	$5.235M	$6.669M
YoY Change	-11.93%	-21.5%	-3.21%
% of Gross Profit	81.61%	136.72%	46.79%
Research & Development	$4.250M	$5.584M	$8.263M
YoY Change	-42.07%	-32.42%	-8.29%
% of Gross Profit	61.64%	145.83%	57.97%
Depreciation & Amortization	$1.190M	$1.060M	$1.060M
YoY Change	9.17%	0.0%	-23.74%
% of Gross Profit	17.26%	27.68%	7.44%
Operating Expenses	$9.877M	$10.82M	$14.93M
YoY Change	-41.0%	-27.54%	-6.09%
Operating Profit	-$2.982M	-$6.990M	-$678.0K
YoY Change	-72.92%	930.97%	-92.88%
Interest Expense	$220.0K	$90.00K	$50.00K
YoY Change	-2300.0%	80.0%	-61.54%
% of Operating Profit
Other Income/Expense, Net	$220.0K	$92.00K	$48.00K
YoY Change	-2850.0%	91.67%
Pretax Income	-$2.762M	-$6.898M	-$630.0K
YoY Change	-74.93%	994.92%	-93.29%
Income Tax	-$17.00K	-$486.0K	$863.0K
% Of Pretax Income
Net Earnings	-$2.745M	-$6.412M	-$1.493M
YoY Change	-65.72%	329.47%	-78.77%
Net Earnings / Revenue	-14.36%	-37.76%	-4.7%
Basic Earnings Per Share
Diluted Earnings Per Share	-$114.9K	-$269.4K	-$64.03K
COMMON SHARES
Basic Shares Outstanding	23.79M shares	23.78M shares
Diluted Shares Outstanding	23.93M shares	23.79M shares	23.27M shares

Balance Sheet

Concept	2013 Q3	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$65.10M	$68.60M	$66.10M
YoY Change	-4.82%	3.78%	-13.14%
Cash & Equivalents	$16.63M	$22.25M	$12.60M
Short-Term Investments	$48.40M	$46.30M	$53.50M
Other Short-Term Assets	$1.011M	$965.0K	$10.90M
YoY Change	-89.58%	-91.15%	6.86%
Inventory	$25.79M	$25.63M	$19.80M
Prepaid Expenses
Receivables	$16.10M	$17.50M	$25.90M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$108.7M	$113.1M	$122.8M
YoY Change	-8.72%	-7.94%	-2.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.07M	$12.33M	$13.90M
YoY Change	-1.02%	-11.31%	-9.15%
Goodwill
YoY Change
Intangibles	$5.180M	$5.459M
YoY Change
Long-Term Investments	$20.70M	$19.70M	$37.30M
YoY Change	-31.91%	-47.18%	-28.68%
Other Assets	$478.0K	$531.0K	$27.20M
YoY Change	-98.29%	-98.05%	33.99%
Total Long-Term Assets	$52.64M	$51.60M	$102.9M
YoY Change	-45.17%	-49.85%	-9.02%
TOTAL ASSETS
Total Short-Term Assets	$108.7M	$113.1M	$122.8M
Total Long-Term Assets	$52.64M	$51.60M	$102.9M
Total Assets	$161.4M	$164.7M	$225.7M
YoY Change	-24.99%	-27.05%	-5.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.719M	$6.491M	$5.800M
YoY Change	-23.89%	11.91%	13.73%
Accrued Expenses	$6.111M	$4.520M	$17.50M
YoY Change	-50.72%	-74.17%	15.13%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$23.22M	$25.27M	$25.30M
YoY Change	8.5%	-0.11%	0.8%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$9.250M	$9.328M	$10.20M
YoY Change	-1.6%	-8.55%	-7.27%
Total Long-Term Liabilities	$9.250M	$9.328M	$10.20M
YoY Change	-1.6%	-8.55%	-7.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.22M	$25.27M	$25.30M
Total Long-Term Liabilities	$9.250M	$9.328M	$10.20M
Total Liabilities	$32.47M	$34.60M	$35.50M
YoY Change	5.42%	-2.54%	-1.66%
SHAREHOLDERS EQUITY
Retained Earnings	-$27.57M	-$24.83M
YoY Change
Common Stock	$155.7M	$154.2M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$128.9M	$130.1M	$190.3M
YoY Change
Total Liabilities & Shareholders Equity	$161.4M	$164.7M	$225.7M
YoY Change	-24.99%	-27.05%	-5.49%

Cashflow Statement

Concept	2013 Q3	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	-$2.745M	-$6.412M	-$1.493M
YoY Change	-65.72%	329.47%	-78.77%
Depreciation, Depletion And Amortization	$1.190M	$1.060M	$1.060M
YoY Change	9.17%	0.0%	-23.74%
Cash From Operating Activities	-$4.200M	-$4.530M	-$4.580M
YoY Change	3.96%	-1.09%	-39.58%
INVESTING ACTIVITIES
Capital Expenditures	-$90.00K	-$540.0K	-$820.0K
YoY Change	-79.55%	-34.15%	-68.7%
Acquisitions
YoY Change
Other Investing Activities	-$2.060M	$2.460M	$2.350M
YoY Change	-123.68%	4.68%	-103.14%
Cash From Investing Activities	-$2.160M	$1.930M	$1.530M
YoY Change	-126.15%	26.14%	-101.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	730.0K	10.00K	-2.370M
YoY Change	2333.33%	-100.42%	-258.0%
NET CHANGE
Cash From Operating Activities	-4.200M	-4.530M	-4.580M
Cash From Investing Activities	-2.160M	1.930M	1.530M
Cash From Financing Activities	730.0K	10.00K	-2.370M
Net Change In Cash	-5.630M	-2.590M	-5.420M
YoY Change	-232.47%	-52.21%	-93.52%
FREE CASH FLOW
Cash From Operating Activities	-$4.200M	-$4.530M	-$4.580M
Capital Expenditures	-$90.00K	-$540.0K	-$820.0K
Free Cash Flow	-$4.110M	-$3.990M	-$3.760M
YoY Change	14.17%	6.12%	-24.19%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	8993000
CY2012Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2494000
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23793138	shares
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6969000
CY2012Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2858000
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12598000
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	748000
CY2013Q1	us-gaap	Restructuring Reserve RestructuringReserve	41000
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	5262000
CY2013Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2225000
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2107841	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.40
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2969612	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	10.63
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.73
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2804636	shares
CY2013Q2	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	1997000
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	25272000
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	670000
CY2013Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4663000
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	6491000
CY2013Q2	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	1281000
CY2013Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4942000
CY2013Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9328000
CY2012Q4	us-gaap	Inventory Net InventoryNet	26193000
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	130052000
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	154187000
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24829000
CY2013Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4520000
CY2013Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2013Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2087000
CY2013Q2	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	4942000
CY2013Q2	us-gaap	Standard Product Warranty Accrual Noncurrent StandardProductWarrantyAccrualNoncurrent	90000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2926000
CY2013Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	8317000
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	24000
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	164652000
CY2013Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	531000
CY2013Q2	us-gaap	Deferred Income Taxes And Other Assets Current DeferredIncomeTaxesAndOtherAssetsCurrent	13500000
CY2013Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	19701000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	557000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	60951000
CY2013Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5459000
CY2013Q2	us-gaap	Inventory Net InventoryNet	25625000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	1195000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	934000
CY2013Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3037000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	853000
CY2013Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	15080000
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12328000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	757000
CY2013Q2	us-gaap	Assets Assets	164652000
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22250000
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	29504000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5459000
CY2013Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	14114000
CY2013Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	88309000
CY2013Q2	us-gaap	Other Assets Current OtherAssetsCurrent	965000
CY2013Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7508000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	854000
CY2013Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	88295000
CY2013Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	82883000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	1195000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8385000
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1289000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	60979000
CY2013Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	17542000
CY2013Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	46344000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1504000
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	82897000
CY2013Q2	us-gaap	Assets Current AssetsCurrent	113050000
CY2013Q2	ivac	Available For Sale Securities Debt Maturities After One Through Two Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue	20709000
CY2013Q2	ivac	Availableforsale Securities Debt Maturities After One Through Two Years Amortized Cost AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsAmortizedCost	20751000
CY2013Q2	ivac	Common Property Plant And Equipment CommonPropertyPlantAndEquipment	1369000
CY2013Q2	ivac	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	42000
CY2013Q2	ivac	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	56000
CY2013Q2	ivac	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses Accumulated In Investments AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLossesAccumulatedInInvestments	56000
CY2013Q2	ivac	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses Accumulated In Investments AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLossesAccumulatedInInvestments
CY2011Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	8715000
CY2011Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2724000
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23560000
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.52
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3128408	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	2259000
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20636000
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	769000
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4194000
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4479000
CY2012Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	1281000
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	5151000
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9232000
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	142635000
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	151996000
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10153000
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8489000
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2012Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2349000
CY2012Q4	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	5151000
CY2012Q4	us-gaap	Standard Product Warranty Accrual Noncurrent StandardProductWarrantyAccrualNoncurrent	90000
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2887000
CY2012Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	2193000
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	23000
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	172503000
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	649000
CY2012Q4	us-gaap	Deferred Income Taxes And Other Assets Current DeferredIncomeTaxesAndOtherAssetsCurrent	12176000
CY2012Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	27317000
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5868000
CY2012Q4	us-gaap	Assets Assets	172503000
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24261000
CY2012Q4	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	12905000
CY2012Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	92094000
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1870000
CY2012Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5526000
CY2012Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	92169000
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2120000
CY2012Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	19822000
CY2012Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	40591000
CY2012Q4	us-gaap	Assets Current AssetsCurrent	112987000
CY2012Q4	ivac	Common Property Plant And Equipment CommonPropertyPlantAndEquipment	1211000
CY2012Q4	ivac	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	86000
CY2012Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5746000
CY2012Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	14921000
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13426000
CY2012Q4	ivac	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	11000
	dei	Trading Symbol TradingSymbol	IVAC
	dei	Entity Registrant Name EntityRegistrantName	INTEVAC INC
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2013-06-29
	dei	Entity Central Index Key EntityCentralIndexKey	0001001902
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	13.19
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23724000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.50
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85	pure
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23724000	shares
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4153000
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	67438	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	23724000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	511133	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2696000	shares
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.62
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	246000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.91
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	419775	shares
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	172000
	us-gaap	Net Income Loss NetIncomeLoss	-14676000
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-431000
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	10000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	22622000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-209000
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	25727000
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div> <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 0px; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><font style="FONT-FAMILY: 'Times New Roman'" size="2"><b>16. Contingencies</b></font></b></font></p> <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: 'Times New Roman'" size="2">From time to time, Intevac may have certain contingent liabilities that arise in the ordinary course of its business activities. Intevac accounts for contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.</font></font></p> </div>
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-336000
	us-gaap	Sales Revenue Net SalesRevenueNet	29965000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-209000
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	835000
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-8242000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	172000
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-99000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	24384000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	22120000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-99000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-15842000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-10000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14775000
	us-gaap	Contracts Revenue ContractsRevenue	7845000
	us-gaap	Gross Profit GrossProfit	7343000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-16014000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-89000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-208000
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	538000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	16480000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1324000
	us-gaap	Contract Revenue Cost ContractRevenueCost	6142000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1144000
	us-gaap	Share Based Compensation ShareBasedCompensation	1082000
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	10523000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2011000
	us-gaap	Operating Expenses OperatingExpenses	23149000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11206000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1166000
	us-gaap	Gross Profit GrossProfit	21078000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7633000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	232000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	2207000
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-10000
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	1072000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1144000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2093000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	319000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1008000
	us-gaap	Product Warranty Expense ProductWarrantyExpense	464000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11943000
	ivac	Minimum Product Warranty Range MinimumProductWarrantyRange	P12M
	ivac	Allocation Of Corporate Expenses To Segments AllocationOfCorporateExpensesToSegments	0.03	pure
	ivac	Unallocated Costs UnallocatedCosts	2685000
	ivac	Maximum Employee Salary Withholdings For Purchase Of Common Stock Under Terms Of Espp MaximumEmployeeSalaryWithholdingsForPurchaseOfCommonStockUnderTermsOfEspp	0.15	pure
	ivac	Share Based Compensation Arrangement By Share Based Payment Award Options Offering Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOfferingPeriod	P2Y
	ivac	Share Based Compensation Arrangement By Share Based Payment Award Conversion Ratio ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRatio	1	EquityPlan
	ivac	Maximum Product Warranty Range MaximumProductWarrantyRange	P24M
	ivac	Product Warranty Range If Systems Sold Through Distributor ProductWarrantyRangeIfSystemsSoldThroughDistributor	P3M
	ivac	Purchase Intervals Of Series PurchaseIntervalsOfSeries	P6M
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23241000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23241000	shares
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10434000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2910000	shares
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	23241000	shares
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	450000
	us-gaap	Sales Revenue Net SalesRevenueNet	49107000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	643000
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1667000
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	7108000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	420000
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	218000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	32987000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	43402000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	137000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7213000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-14000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4517000
	us-gaap	Contracts Revenue ContractsRevenue	5705000
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	874000
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-486000
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	514000
	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	210000
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-5780000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-10962000
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-21000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	420000
	us-gaap	Net Income Loss NetIncomeLoss	-4654000
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-758000
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	501000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	28029000
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	10819000
CY2013Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5235000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	643000
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	32647000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	24086000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2373000
	us-gaap	Contract Revenue Cost ContractRevenueCost	3943000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1507000
	us-gaap	Share Based Compensation ShareBasedCompensation	1998000
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	81000
	us-gaap	Operating Expenses OperatingExpenses	30918000
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	244000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13442000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2559000
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-14000
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	1497000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	882000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2299000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	2389000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	993000
	us-gaap	Product Warranty Expense ProductWarrantyExpense	1190000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17476000
	ivac	Unallocated Costs UnallocatedCosts	2988000
	ivac	Payment Of Acquisition Related Contingent Consideration PaymentOfAcquisitionRelatedContingentConsideration	2389000
CY2013Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.18	pure
CY2013Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	461000
CY2013Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-21000
CY2013Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
CY2013Q1	us-gaap	Restructuring Charges RestructuringCharges	502000
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23265000	shares
CY2012Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2012Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23265000	shares
CY2012Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2871000	shares
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2012Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	23265000	shares
CY2012Q2	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	327000
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	31791000
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	365000
CY2012Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	48000
CY2012Q2	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	75000
CY2012Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	28634000
CY2012Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	40000
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-630000
CY2012Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-26000
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1453000
CY2012Q2	us-gaap	Contracts Revenue ContractsRevenue	3157000
CY2012Q2	us-gaap	Gross Profit GrossProfit	14254000
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-678000
CY2012Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	101000
CY2012Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	447000
CY2012Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	48000
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-1493000
CY2012Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	222000
CY2012Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	17537000
CY2012Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	15266000
CY2012Q2	us-gaap	Contract Revenue Cost ContractRevenueCost	2271000
CY2012Q2	us-gaap	Share Based Compensation ShareBasedCompensation	944000
CY2012Q2	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	35000
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	14932000
CY2012Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6669000
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	863000
CY2012Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	722000
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	2389000
CY2012Q2	us-gaap	Product Warranty Expense ProductWarrantyExpense	410000
CY2012Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8263000
CY2012Q2	ivac	Unallocated Costs UnallocatedCosts	1191000
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23785000	shares
CY2013Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2013Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23785000	shares
CY2013Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2690000	shares
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
CY2013Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	23785000	shares
CY2013Q2	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-257000
CY2013Q2	us-gaap	Payments For Restructuring PaymentsForRestructuring	281000
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	16983000
CY2013Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-320000
CY2013Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	92000
CY2013Q2	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-78000
CY2013Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	13234000
CY2013Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	183000
CY2013Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13154000
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-78000
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6898000
CY2013Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-4000
CY2013Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
CY2013Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	10173000
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6490000
CY2013Q2	us-gaap	Contracts Revenue ContractsRevenue	3749000
CY2013Q2	us-gaap	Gross Profit GrossProfit	3829000
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6990000
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-74000
CY2013Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	329000
CY2013Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-78000
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	92000
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-6412000
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-78000
CY2013Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5000
CY2013Q2	us-gaap	Contract Revenue Cost ContractRevenueCost	2981000
CY2013Q2	us-gaap	Share Based Compensation ShareBasedCompensation	519000
CY2013Q2	us-gaap	Restructuring Charges RestructuringCharges	240000
CY2013Q2	us-gaap	Product Warranty Expense ProductWarrantyExpense	210000
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5584000
CY2013Q2	ivac	Unallocated Costs UnallocatedCosts	1402000

Files In Submission

Name	View Source	Status
0001193125-13-310182-index-headers.html	Edgar Link	pending
0001193125-13-310182-index.html	Edgar Link	pending
0001193125-13-310182.txt	Edgar Link	pending
0001193125-13-310182-xbrl.zip	Edgar Link	pending
d550418d10q.htm	Edgar Link	pending
d550418dex101.htm	Edgar Link	pending
d550418dex311.htm	Edgar Link	pending
d550418dex312.htm	Edgar Link	pending
d550418dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
ivac-20130629.xml	Edgar Link	completed
ivac-20130629.xsd	Edgar Link	pending
ivac-20130629_cal.xml	Edgar Link	unprocessable
ivac-20130629_def.xml	Edgar Link	unprocessable
ivac-20130629_lab.xml	Edgar Link	unprocessable
ivac-20130629_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R40.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R41.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R42.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R43.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R44.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R45.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R46.xml	Edgar Link	unprocessable
R47.htm	Edgar Link	pending
R47.xml	Edgar Link	unprocessable
R48.htm	Edgar Link	pending
R48.xml	Edgar Link	unprocessable
R49.htm	Edgar Link	pending
R49.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R50.htm	Edgar Link	pending
R50.xml	Edgar Link	unprocessable
R51.htm	Edgar Link	pending
R51.xml	Edgar Link	unprocessable
R52.htm	Edgar Link	pending
R52.xml	Edgar Link	unprocessable
R53.htm	Edgar Link	pending
R53.xml	Edgar Link	unprocessable
R54.htm	Edgar Link	pending
R54.xml	Edgar Link	unprocessable
R55.htm	Edgar Link	pending
R55.xml	Edgar Link	unprocessable
R56.htm	Edgar Link	pending
R56.xml	Edgar Link	unprocessable
R57.htm	Edgar Link	pending
R57.xml	Edgar Link	unprocessable
R58.htm	Edgar Link	pending
R58.xml	Edgar Link	unprocessable
R59.htm	Edgar Link	pending
R59.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R60.htm	Edgar Link	pending
R60.xml	Edgar Link	unprocessable
R61.htm	Edgar Link	pending
R61.xml	Edgar Link	unprocessable
R62.htm	Edgar Link	pending
R62.xml	Edgar Link	unprocessable
R63.htm	Edgar Link	pending
R63.xml	Edgar Link	unprocessable
R64.htm	Edgar Link	pending
R64.xml	Edgar Link	unprocessable
R65.htm	Edgar Link	pending
R65.xml	Edgar Link	unprocessable
R66.htm	Edgar Link	pending
R66.xml	Edgar Link	unprocessable
R67.htm	Edgar Link	pending
R67.xml	Edgar Link	unprocessable
R68.htm	Edgar Link	pending
R68.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IVAC
INTEVAC INC Stock $ivac

2013 Q3 Form 10-Q Financial Statement

#000119312513310182 Filed on July 30, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVAC INTEVAC INC Stock $ivac

2013 Q3 Form 10-Q Financial Statement

#000119312513310182 Filed on July 30, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVAC
INTEVAC INC Stock $ivac